Is there a treatment advantage when paclitaxel and lovastatin are combined to dose anaplastic thyroid carcinoma cell lines?
- Yoo Seung Chung
- , Sujin Cho
- , Hee Joo Ryou
- , Hyeon Gun Jee
- , June Young Choi
- , Kwan Yoon
- , Hyuk Jae Choi
- , Kyu Eun Lee
- , Young Jin Suh
- , Seung Keun Oh
- , Yeo Kyu Youn
- The Catholic University of Korea, St. Vincent's Hospital
- Gachon University
- Seoul National University
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations